Results for:(45 found)
Feb 11, 2013 1:05PM on Top StocksBy MSN Money Partner

Green Mountain is downgraded to 'neutral,' and Wells Fargo is upgraded to 'buy.'

Feb 4, 2013 12:37PM on Top StocksBy TheStreet Staff

A report questions whether the FDA will grant New Chemical Entity status for the phosphate binder.

Jan 25, 2013 12:10PM on Top StocksBy MSN Money Partner

Ford is downgraded to 'equal weight,' and Saks is initiated with a 'buy.'

Jan 22, 2013 11:25AM on Top StocksBy MSN Money Partner

Morgan Stanley is downgraded to 'neutral,' and State Street is upgraded to 'neutral.'

Nov 9, 2012 12:33PM on Top StocksBy MSN Money Partner

Groupon is downgraded to 'equal weight,' while Isis Pharmaceuticals is upgraded to 'outperform.'

Nov 7, 2012 12:15PM on Top StocksBy Minyanville.com

The pharma wins US approval for a new rheumatoid arthritis pill, but Abbott's existing treatment isn't likely to suffer a meaningful hit to sales anytime soon.

Oct 26, 2012 2:33PM on Top StocksBy Minyanville.com

The stock falls after investors get a peek at the royalty-rate structure that pharma giant Roche will pay if a promising new cancer drug is approved.

Oct 11, 2012 12:47PM on Top StocksBy Minyanville.com

Tech, biotech and volatility funds are leading the way so far.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2013 Microsoft. All rights reserved.

Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.

Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.

Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.

TOP STOCKS

The market's most controversial stock?

This young tech company has a can't-miss concept, but hasn't yet generated real sales. Should you see its recent slump as a buying opportunity, or reason to stay away?

More

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More

SMART SPENDING

Plastic paychecks shrink salaries, suit says

A single mom who says she was forced to accept a fee-heavy 'payroll card' instead of a check or direct deposit is taking a McDonald's franchise to court.

More

SMART TAXES

More